Additional Details
-
A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
Clinical Research of Rock HillRock Hill SC. 29732View Details -
A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
Tennessee Comprehensive Lung and Sleep CenterHendersonville TN. 37075View Details -
A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
SEC Clinical Research LLCDothan AL. 36305View Details -
A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
Hannibal Regional Healthcare System, Inc.Hannibal MO. 63401View Details -
A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
Premier Pulmonary Critical Care and Sleep Medicine, PADenison TX. 75020View Details -
Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study
University of Miami Hospital and ClinicsMiami FL. 33136View Details -
Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
IdahoBoise ID. 83706View Details -
Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
PhoenixPhoenix AZ. 85020View Details -
Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
Allen ParkAllen Park MI. 48101View Details -
Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
San FranciscoSan Francisco CA. 94143View Details -
A Clinical Trial of NS-863 in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
StatCare Pulmonary Consultants, PLLCKnoxville TN. 37919View Details -
Nebulized Human Amniotic Fluid in Patients With Interstitial Lung Disease
Maule Stem Cell Research InstituteVenice FL. 34292View Details -
A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)
M Health Fairview Masonic Children's HospitalMinneapolis MN. 55454View Details -
A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)
Alberta Children's HospitalCalgary AB. T3B 6A8View Details -
A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)
Children's Hospital Los AngelesLos Angeles CA. 90027View Details -
A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)
Children's Hospital of PhiladelphiaPhiladelphia PA. 19104View Details -
A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)
Johns Hopkins HospitalBaltimore MD. 21287View Details -
A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)
Children's Hospital ColoradoAurora CO. 80045View Details -
A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)
Nationwide Children's HospitalColumbus OH. 43205View Details -
A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)
Boston Children's HospitalBoston MA. 02115View Details
